Abstract

A wide range of protozoan pathogens either transmitted by vectors (, , and ), by contaminated food or water ( and ), or by sexual contact () invade various organs in the body and cause prominent human diseases, such as malaria, babesiosis, leishmaniasis, trypanosomiasis, diarrhea, and trichomoniasis. Humans are frequently exposed to multiple pathogens simultaneously, or sequentially in the high-incidence regions to result in co-infections. Consequently, synergistic or antagonistic pathogenic effects could occur between microbes that also influences overall host responses and severity of diseases. The co-infecting organisms can also follow independent trajectory. In either case, co-infections change host and pathogen metabolic microenvironments, compromise the host immune status, and affect microbial pathogenicity to influence tissue colonization. Immunomodulation by protozoa often adversely affects cellular and humoral immune responses against co-infecting bacterial pathogens and promotes bacterial persistence, and result in more severe disease symptoms. Although co-infections by protozoa and viruses also occur in humans, extensive studies are not yet conducted probably because of limited animal model systems available that can be used for both groups of pathogens. Immunosuppressive effects of protozoan infections can also attenuate vaccines efficacy, weaken immunological memory development, and thus attenuate protection against co-infecting pathogens. Due to increasing occurrence of parasitic infections, roles of acute to chronic protozoan infection on immunological changes need extensive investigations to improve understanding of the mechanistic details of specific immune responses alteration. In fact, this phenomenon should be seriously considered as one cause of breakthrough infections after vaccination against both bacterial and viral pathogens, and for the emergence of drug-resistant bacterial strains. Such studies would facilitate development and implementation of effective vaccination and treatment regimens to prevent or significantly reduce breakthrough infections.

MeSH

Bacterial Infections, Vaccines, Coinfection, Vaccination, Immunity, Parasites, Protozoan Infections, Infections, Vaccine Efficacy, Breakthrough Infections

Cited by

• Concomitant Infection of Helicobacter pylori and Intestinal Parasites: Burden, Sociodemographic and Clinical Characteristics in Hospitalized Children and Adolescents in Northern Lebanon. F1000Res, 2025
• Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional study. Sci Rep, 2023
• and mutually exacerbate damage to corneal cells during coinfection. Microbiol Spectr, 2024
• Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana. Exp Biol Med (Maywood), 2025
• Humans seropositive for Trypanosoma cruzi co-infected with intestinal helminths have higher infectiousness, parasitaemia and Th2-type response in the Argentine Chaco. Parasit Vectors, 2024
• P21 recombinant protein modulates infection in different experimental models of the human maternal-fetal interface. Front Immunol, 2023
• Common intestinal parasitic infections in an improved water access, sanitation, and hygiene profile setting in North Jakarta, Indonesia. Narra J, 2025
• COVID-19 and Diarylamidines: The Parasitic Connection. Int J Mol Sci, 2023